Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-015820
Filing Date
2023-09-15
Accepted
2023-09-15 16:35:26
Documents
21
Period of Report
2023-11-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A pahc-20231106xdef14a.htm   iXBRL DEF 14A 1145077
2 GRAPHIC pahc-20231106xdef14a_a003.jpg GRAPHIC 10068
3 GRAPHIC pahc-20231106xdef14a_a004.jpg GRAPHIC 5247
4 GRAPHIC pahc-20231106xdef14a_a012.jpg GRAPHIC 64680
5 GRAPHIC pahc-20231106xdef14a_a013.jpg GRAPHIC 62610
6 GRAPHIC pahc-20231106xdef14a_a014.jpg GRAPHIC 61556
7 GRAPHIC pahc-20231106xdef14a_a015.jpg GRAPHIC 42728
8 GRAPHIC pahc-20231106xdef14a_bg001.jpg GRAPHIC 163845
9 GRAPHIC pahc-20231106xdef14a_cg001.jpg GRAPHIC 107664
  Complete submission text file 0001558370-23-015820.txt   3074131

Data Files

Seq Description Document Type Size
10 EX-101.SCH pahc-20231106.xsd EX-101.SCH 6641
11 EX-101.DEF pahc-20231106_def.xml EX-101.DEF 49656
12 EX-101.LAB pahc-20231106_lab.xml EX-101.LAB 7153
13 EX-101.PRE pahc-20231106_pre.xml EX-101.PRE 5668
16 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20231106xdef14a_htm.xml XML 136264
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-36410 | Film No.: 231259199
SIC: 2834 Pharmaceutical Preparations